Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Indication Renal biopsies and outcomes in patient receiving ABO incompatible renal transplantation. Indian institutional experience
저자 Pallav Gupta
출판정보 2021; 2021(1):
키워드
초록 Objective: Retrospective study (January 2012 to June 2019).164 patients were included in the study. Biochemical parameters, serial IgG Anti-ABO titres and class I and II DSA findings recorded. Graft biopsies were reviewed in detail according to the Banff 2017 update.  Methods: 65 biopsies from 54 patients were reexamined. Acute antibody mediated rejection (12.8%) was more than acute cellular rejection (1.8%). AMR cases had evidence of microvascular inflammation (g+ptc≥2) and C4d positivity in 100% cases. Acute tubular injury (ATN) alone was seen in 10.3 % patients. 65% of these patients had C4d positivity in peritubular capillaries(mild to moderate) and only one case developed chronic active antibody mediated rejection on follow up. 1 year patient and death censored graft survival after transplantation was 92% and 98% respectively and at 3 year it was 88% and 91%. Patients with AMR had reduced patient (76.5%) and death censored graft survival (84.6%) at 1 year. Results: AMR can be reliably diagnosed in ABO-i transplants by looking at microvascular inflammation (g+ptc≥2) score. Acute tubular injury with C4d positivity without microvascular injury does not confirm AMR.  We recommend specific diagnostic criteria for ABO-incompatible transplants in Banff classification. Conclusions: Objective: ABO-i renal transplantation has gained momentum and over the last decade it has helped to expand the donor pool.Many studies describing protocol biopsies in ABO-i transplant patients have been published in literature. Present study describes renal biopsy findings in  indication renal biopsies performed for graft dysfunction. Methods: Retrospective study (January 2012 to June 2019).164 patients were included in the study. Biochemical parameters, serial IgG Anti-ABO titres and class I and II DSA findings recorded. Graft biopsies were reviewed in detail according to the Banff 2017 update.  Results: 65 biopsies from 54 patients were reexamined. Acute antibody mediated rejection (12.8%) was more than acute cellular rejection (1.8%). AMR cases had evidence of microvascular inflammation (g+ptc≥2) and C4d positivity in 100% cases. Acute tubular injury (ATN) alone was seen in 10.3 % patients. 65% of these patients had C4d positivity in peritubular capillaries(mild to moderate) and only one case developed chronic active antibody mediated rejection on follow up. 1 year patient and death censored graft survival after transplantation was 92% and 98% respectively and at 3 year it was 88% and 91%. Patients with AMR had reduced patient (76.5%) and death censored graft survival (84.6%) at 1 year. Conclusions: AMR can be reliably diagnosed in ABO-i transplants by looking at microvascular inflammation (g+ptc≥2) score. Acute tubular injury with C4d positivity without microvascular injury does not confirm AMR.  We recommend specific diagnostic criteria for ABO-incompatible transplants in Banff classification.
원문(PDF) PDF 원문보기
위로가기